View the ALXN U.S. Securities and Exchange Commission reporting information. The Board of Directors of Alexion Pharmaceuticals, Inc. is soliciting your proxy to vote your shares at our 2020 Annual Meeting of Shareholders (Annual Meeting) to be held at 5:30 p.m. local time, on Wednesday, May 13, 2020 for the purposes summarized in the accompanying Notice of 2020 Annual Meeting of Shareholders. Total revenues for the full year of 2020 were $6,069.9 million, a 22 percent increase compared to the same period in 2019. BOSTON, May 6, 2020 - Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced financial results for the first quarter of 2020.Total revenues in the first quarter were $1,444.8 million, a 27 percent increase compared to the same period in 2019.The negative impact of foreign currency on total revenues year-over-year was 1 percent, or $15.7 million, inclusive of hedging activities. Paper copies of our SEC reports are available free of charge upon request in writing to Investor Relations, Alexion Pharmaceuticals, Inc., 100 College Street, New Haven, Connecticut 06510. Paper copies of our SEC reports are available free of charge upon request in writing to Investor Relations, Alexion Pharmaceuticals, Inc., 352 Knotter Drive, Cheshire, CT 06410. The information found on our website is not part of this or any other report we file with, or furnish to, the SEC. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Alexion Pharmaceuticals, Inc.. View ALXN's latest 10K form and other filings with the Securities and Exchange Commission at MarketBeat. ALEXION PHARMACEUTICALS Inc sec form 4 filings insider trading, stock buying and selling. Find the latest SEC Filings data for Alexion Pharmaceuticals, Inc. Common Stock (ALXN) at Nasdaq.com. The negative impact of foreign currency on total revenues year-over-year was 1 percent, or $52.0 million, inclusive of hedging activities. Alexion Pharmaceuticals Inc. SEC filings breakout by MarketWatch. View the ALXN report for unscheduled material events or corporate changes by date. Are you researching Alexion Pharmaceuticals (NASDAQ:ALXN) stock for your portfolio? Latest SEC filings for Alexion Pharmaceuticals, Inc. (ALXN). SEC Filings Group 3,4,5 Annual Filings Current Reports Mergers & Acquisitions Other Proxy Filings Quarterly Filings Registration Statements Filing year - Any - 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 … Without admitting or denying the SEC’s findings, Alexion agreed to cease and desist from committing violations of the books and records and internal accounting controls provisions of the FCPA and pay $14,210,194 in disgorgement, $3,766,337 in prejudgment interest, and a $3.5 million penalty. - Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced financial results for the fourth quarter and full year of 2020. Alexion Pharmaceuticals, Inc is primarely in the business of pharmaceutical preparations. Alexion Pharmaceuticals Inc. 8k SEC filings breakout by MarketWatch. For financial reporting, their fiscal year ends on December 31st.
Zulassungsstelle Heilbronn Telefonnummer, Gemeinde Borchen Stellenangebote, Anna Biondi Parfum Aldi, Handball Weltmeister 1974, Schlachthof Nürnberg öffnungszeiten, Anna Julia Antonucci, Johanna Von England,
Neue Kommentare